185 related articles for article (PubMed ID: 35667092)
1. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study.
Ose J; Gigic B; Hardikar S; Lin T; Himbert C; Warby CA; Peoples AR; Lindley CL; Boehm J; Schrotz-King P; Figueiredo JC; Toriola AT; Siegel EM; Li CI; Ulrich A; Schneider M; Shibata D; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1650-1660. PubMed ID: 35667092
[TBL] [Abstract][Full Text] [Related]
2. Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.
Himbert C; Ose J; Nattenmüller J; Warby CA; Holowatyj AN; Böhm J; Lin T; Haffa M; Gigic B; Hardikar S; Scherer D; Zielske L; Schrotz-King P; Kölsch T; Siegel EM; Shibata D; Ulrich A; Schneider M; Hursting SD; Kauczor HU; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):76-82. PubMed ID: 30333223
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer.
Nogués A; Gallardo-Vara E; Zafra MP; Mate P; Marijuan JL; Alonso A; Botella LM; Prieto MI
World J Surg Oncol; 2020 May; 18(1):99. PubMed ID: 32434528
[TBL] [Abstract][Full Text] [Related]
4. Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study.
Himbert C; Ose J; Lin T; Warby CA; Gigic B; Steindorf K; Schrotz-King P; Abbenhardt-Martin C; Zielske L; Boehm J; Ulrich CM
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13055. PubMed ID: 31016796
[TBL] [Abstract][Full Text] [Related]
5. Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.
Tabernero J; Hozak RR; Yoshino T; Cohn AL; Obermannova R; Bodoky G; Garcia-Carbonero R; Ciuleanu TE; Portnoy DC; Prausová J; Muro K; Siegel RW; Konrad RJ; Ouyang H; Melemed SA; Ferry D; Nasroulah F; Van Cutsem E
Ann Oncol; 2018 Mar; 29(3):602-609. PubMed ID: 29228087
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients.
Dymicka-Piekarska V; Guzinska-Ustymowicz K; Kuklinski A; Kemona H
Thromb Res; 2012 Apr; 129(4):e47-50. PubMed ID: 22209338
[TBL] [Abstract][Full Text] [Related]
8. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
[TBL] [Abstract][Full Text] [Related]
10. Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study.
Lindley CL; Gigic B; Peoples AR; Han CJ; Lin T; Himbert C; Warby CA; Boehm J; Hardikar S; Ashworth A; Schneider M; Ulrich A; Schrotz-King P; Figueiredo JC; Li CI; Shibata D; Siegel EM; Toriola AT; Ulrich CM; Syrjala KL; Ose J
Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):363-370. PubMed ID: 36595657
[TBL] [Abstract][Full Text] [Related]
11. Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer.
Jeon JY; Jeong DH; Park MG; Lee JW; Chu SH; Park JH; Lee MK; Sato K; Ligibel JA; Meyerhardt JA; Kim NK
PLoS One; 2013; 8(2):e55196. PubMed ID: 23405123
[TBL] [Abstract][Full Text] [Related]
12. One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.
Kiblawi R; Holowatyj AN; Gigic B; Brezina S; Geijsen AJMR; Ose J; Lin T; Hardikar S; Himbert C; Warby CA; Böhm J; Bours MJL; van Duijnhoven FJB; Gumpenberger T; Kok DE; Koole JL; van Roekel EH; Schrotz-King P; Ulvik A; Gsur A; Habermann N; Weijenberg MP; Ueland PM; Schneider M; Ulrich A; Ulrich CM; Playdon M
Br J Nutr; 2020 May; 123(10):1187-1200. PubMed ID: 32019627
[TBL] [Abstract][Full Text] [Related]
13. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
[TBL] [Abstract][Full Text] [Related]
14. Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.
Suliman ME; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P
Nephrol Dial Transplant; 2006 Jun; 21(6):1603-10. PubMed ID: 16476720
[TBL] [Abstract][Full Text] [Related]
15. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.
Giessen C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Michl M; Heinemann V; Stieber P; Schulz C
Tumour Biol; 2014 Oct; 35(10):10237-48. PubMed ID: 25027407
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
18. Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.
Holowatyj AN; Ose J; Gigic B; Lin T; Ulvik A; Geijsen AJMR; Brezina S; Kiblawi R; van Roekel EH; Baierl A; Böhm J; Bours MJL; Brenner H; Breukink SO; Chang-Claude J; de Wilt JHW; Grady WM; Grünberger T; Gumpenberger T; Herpel E; Hoffmeister M; Keulen ETP; Kok DE; Koole JL; Kosma K; Kouwenhoven EA; Kvalheim G; Li CI; Schirmacher P; Schrotz-King P; Singer MC; van Duijnhoven FJB; van Halteren HK; Vickers K; Vogelaar FJ; Warby CA; Wesselink E; Ueland PM; Ulrich AB; Schneider M; Habermann N; Kampman E; Weijenberg MP; Gsur A; Ulrich CM
Am J Clin Nutr; 2022 Aug; 116(2):303-313. PubMed ID: 35394006
[TBL] [Abstract][Full Text] [Related]
19. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
[TBL] [Abstract][Full Text] [Related]
20. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.
Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S
Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
